Infinium Global Research Acute Lymphocytic Leukemia Market | Page 2

A latest report has been added to the wide database of Acute Lymphocytic Leukemia Market by Infinium Global Research.
This report studies the Acute Lymphocytic Leukemia Market by therapeutics (drugs are sub segmented into CALGB 8811
regimen; pipeline drugs are sub segmented into margibo, graspa), rout of administration (oral and parental), types of
molecule (biologics and small molecules) market status and outlook of global and major regions, from manufacturers, and
end industries. The objective of the study is to identify market sizes of different segments & countries in recent years and to
forecast the values for the next six years. Acute Lymphocytic Leukemia Market provides opportunities in micro markets for
stakeholders to invest along with the detailed analysis of competitive landscape, latest trends, and product offerings of the
major companies in the Acute Lymphocytic Leukemia Market. According to the report the Global Acute Lymphocytic
Leukemia Market is projected to grow at a CAGR of 5.7% in terms of value over the period of 2017-2023.
Acute Lymphocytic Leukemia (ALL) is also known as acute lymphoblastic leukemia, is a cancer of white blood cell or bone
marrow, which occurs due to overproduction and accumulation of cancerous white blood cell, known as lymphoblasts. ALL is
an acute form of leukemia which majorly affects the lymphoid system, blood and bone marrow. This type of leukemia is
more dominant in infants; however, it can be also diagnosed in adults. The common symptoms of ALL a patient exhibits are
weakness, tiredness, dizziness, fever, shortness of breath, frequent infections, bruising, and bleeding. Globally, the growing
awareness about ALL among the consumers has primarily driven the demand for drugs and treatment of acute lymphocytic
leukemia.The growth in acute lymphocytic leukemia market is primarily driven by unmet healthcare needs coupled with
innovative therapies. Moreover, provision for orphan drugs is majorly contributing to the growth of this market. However,
High cost of production, adverse effect of drugs and entry of generics are considered to be the major restraining factors that
are likely to hinder the growth of this market over the forecast period. Yet, the global acute lymphocytic leukemia market is
expected to present several opportunities to the leading players in the market over the forecast period, due to growing
unmet healthcare needs and minimal competition.
Segment Covered
The report on global acute lymphocytic leukemia market covers segments such as, therapeutics, route of administration and
molecule type. On the basis of therapeutics the global acute lymphocytic leukemia market is categorized into existing drugs
and pipeline drugs. Existing drugs are further sub segmented into CALGB 8811 regimen, hyper CVD regimen, linker regimen,
nucleoside regimen and on Casper; Pipeline drugs are further sub segmented into margibo, graspa, inotuzumabozogamicin.
On the basis of route of administration the global acute lymphocytic leukemia market is categorized into oral and parental.
Infinium Global Research